IMMUNITYBIO, INC.

IBRX ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2024

Total Assets: $382.9M

Liabilities Breakdown FY2024

Total Liabilities: $871.1M